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Abstract: The most common cause for dental composite failures is secondary caries due to invasive
bacterial colonization of the adhesive/dentin (a/d) interface. Innate material weakness often lead to
an insufficient seal between the adhesive and dentin. Consequently, bacterial by-products invade the
porous a/d interface leading to material degradation and dental caries. Current approaches to achieve
antibacterial properties in these materials continue to raise concerns regarding hypersensitivity and
antibiotic resistance. Herein, we have developed a multi-faceted, bio-functionalized approach
to overcome the vulnerability of such interfaces. An antimicrobial adhesive formulation was
designed using a combination of antimicrobial peptide and a ε-polylysine resin system. Effector
molecules boasting innate immunity are brought together with a biopolymer offering a two-fold
biomimetic design approach. The selection of ε-polylysine was inspired due to its non-toxic nature
and common use as food preservative. Biomolecular characterization and functional activity of
our engineered dental adhesive formulation were assessed and the combinatorial formulation
demonstrated significant antimicrobial activity against Streptococcus mutans. Our antimicrobial
peptide-hydrophilic adhesive hybrid system design offers advanced, biofunctional properties at the
critical a/d interface.
Keywords: antimicrobial peptide; polylysine; adhesive formulation; hybrid interface; dental composites
1. Introduction
Despite the significant increase in the usage of composite materials in restorative dentistry,
their reduced average lifetime remains a major concern [1]. Clinical data suggest that over half of
all restorative operations performed in contemporary dentistry are procedures aimed to replace
or repair regions at which previous restorations have failed [2]. These failures are primarily
attributed to recurrent caries and infection [3]. The majority of composite restoration failures
across all patient groups are linked to the local infiltration and colonization of harmful bacteria.
Invasive bacteria can infiltrate weak or impaired regions at the adhesive-dentin (a/d) interface
leading to further biodegradation and secondary loss of adhesion, microleakage, and decay [4].
This vulnerable interface has been identified as the weakest link for the reduced durability of modern
composite restorations [2,4–14]. Therefore, it is critical to design novel, enhanced composite adhesive
formulations aimed to achieve improved interfacial binding and provide protection against bacterial
colonization at the susceptible a/d interface.
Appl. Sci. 2019, 9, 557; doi:10.3390/app9030557 www.mdpi.com/journal/applsci
Appl. Sci. 2019, 9, 557 2 of 19
Various approaches have been investigated to improve the longevity of restorative composite.
In our recent study, lysine incorporation into a dental adhesive system similar to a HEMA/Bis-GMA
based commercial analog resulted in neutralization. Modulating the pH of the dental adhesive
by adding a single amino acid, lysine, can lead to overcome the adverse effects of the acidic
microenvironment and enhance the durability of composite restorations [15]. Other approaches
explored to incorporate antimicrobial agents, and consecutively develop antimicrobial properties in
the restorative composites. These approaches include the use of zinc- or silver-based nanoparticles
with innate antimicrobial properties through metallic ion release [16–18]. Other techniques have
relied on the use of quaternary ammonium compounds (QACs) chemically bound to (immobilized)
or copolymerized with the composite monomer formulation [18–21]. Additionally, several studies
have designed composite materials which release low-molecular weight antibacterial agents such
as chlorhexidine (CHX) [20]. Although many groups have published promising data using these
approaches, limitations have also been reported. Determining appropriate nanoparticle size and
concentration as well as an optimal technique for stabilization or immobilization and incorporation
within the adhesive resin has been difficult. Additionally, QAC-related antimicrobial resistance
has been shown to occur at sub-inhibitory concentrations through both intrinsic and acquired
resistance mechanisms [22–24]. Though CHX is recognized as the most effective chemical antiplaque
agent [25–28], its limitations include adverse effects for taste, mouth discoloration, mucosal irritation,
and desquamation of the gums [29,30].
The emergence of drug-resistant bacteria is another major driving force for seeking new
antibacterial agents to replace current antibiotics to prevent and fight bacterial infections [31–33].
Antimicrobial peptides, which are naturally integrated in the oral fluids [34–36], are a promising
solution to prevent bacterial infections at the a/d interface since they are selective, biodegradable, and
can remain active across evolutionary time scales [37–40]. Thus, antimicrobial peptides have been
increasingly explored for medical use over the last decade. While antimicrobial peptides may have
higher inhibitory concentrations than other agents, they also have less mammalian cellular toxicity,
no staining effect, and minimal observed bacterial resistance rates [41]. The efficacy of antimicrobial
peptides is postulated to be dependent upon their secondary structure characteristics that reveal
the pattern of hydrogen bonding in the peptide backbone [42]. Our group has previously evaluated
the secondary structure features of antimicrobial peptides through circular dichroism [43,44]. This
technique uses the preferential absorption of left-handed or right-handed elliptically polarized light to
observe changes in the peptide backbone. Apparent differences in the circular dichroism spectra may
indicate functional changes of the peptides, owing to the conditional harmony of structure–function
relationships [45]. Due to its advantageous properties, antimicrobial peptides have been used for
various applications in the pharmaceutical and food industries [46]. Significant progress has been made
in recent years on the control of oral pathogens, such as S. mutans, with antimicrobial peptides [47].
Currently, antimicrobial peptides (AMPs), derived from both natural and synthetic sources, have
shown inhibition of S. mutans [48,49]. AMPs have been used for various dental application research.
Aida, et al., 2018 have developed an antimicrobial peptide loaded drug delivery system to prevent
dental caries [50]. AMP has also been showed to reduce periodontal pathogens [51]. Antimicrobial
peptides have also been incorporated in dental titanium implants [52,53]. GL13K, a derivative of an
oral peptide, inhibited bacterial activity on the titanium surface when immobilized through covalent
linkages. Our group explored antimicrobial peptides to inhibit the activity of bacteria on the titanium
surface using a solid-binding peptide based non-covalent immobilization strategy. Over the last decade,
we have identified and designed a wide range of solid material binding peptides and utilized these
peptides by coupling with diverse bioactivities as chimeric biomolecules. The use of solid-binding
peptides enabled the chimeric peptides self assemble onto different material surfaces and resulted
in enhanced variety of bioactivities including antibacterial, cell targeting, and signaling to guide
cell fate [43,44,54–57]. In a recent study, nisin, an antimicrobial peptide, was used to make a cured
nisin-incorporated dental adhesive that exhibited a significant inhibitory effect on the growth of
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S. mutans. The inhibitory effect was strengthened as the nisin concentration increased however, there
were no significant differences in the agar diffusion test for the cured nisin-incorporated adhesives
when compared to the control group [58,59].
ε-Polylysine (ε-pL) is already recognized for its safe use as a commercial food preservative due
to its natural antimicrobial properties [60,61]. As a small homopolymer, ε-pL, was approved by the
FDA as a food additive, noting its antimicrobial activity and low toxicity to human cells [62]. Panpisut
and colleagues recently explored polylysine addition to the mixture of monocalcium phosphate
monohydrate and tristrontium phosphate into a dental composite system and demonstrated increased
apatite layer thickness [63].
Herein, we propose a novel, bio-enabled dental adhesive system with multiple antibacterial
mechanisms and innate biocompatibility to address the critical weakness of bacteria-induced
degradation at the a/d interface. We explore the effects of adding ε-pL to our dental adhesive
formulation and incorporating antimicrobial peptide to the adhesive system as part of our approach
to provide multiple antibacterial mechanisms. First, we developed an amine-functionalized dental
adhesive formulation, building upon our previous work which addressed the challenges of the
hydration difference between the dental adhesive and the demineralized dentin [64–66]. Next,
we added ε-pL to the adhesive formulation coupled with antimicrobial peptides as an additional
mechanism to combat bacterial colonization at the a/d interface. To achieve this goal, we engineered
derivatives of an established antimicrobial peptide, GH12, with known activity against S. mutans [67].
GH12 has been shown to reduce the cariogenic virulence factors of S. mutans, an activity that makes
GH12 a candidate for dental caries prevention [68]. In addition, GH12 was successfully employed in a
rodent model in a pioneer study aimed to analyze the efficacy of an antimicrobial peptide on the onset
and development of dental caries [69]. Promising sequence derivatives were selected for synthesis
through computational structure generation verified via analysis of GH12 and modified peptide
folding using circular dichroism in the presence of a kosmotropic agent. To ensure effective activity,
the peptide was designed to allow for amine coupling to the enhanced dental adhesive formulation
through the addition of a spacer sequence. Our results demonstrate that the addition of both ε-pL
and the engineered antimicrobial peptide components provide critical bacterial inhibition for the
adhesive formulations.
2. Materials and Methods
2.1. Materials
Chlorhexidine digluconate (CHX) was from Sigma-Aldrich. BD™ Bacto™ brain heart infusion,
BD BBL dehydrated brain heart infusion agar, and Corning™ Clear polystyrene 96-well microplates,
Corning™ 3370 were obtained from Fisher. AlamarBlue assay kit was obtained from Fisher.
Triethylene glycol dimethacrylate (TEGDMA), 2-hydroxyethylmethacrylate (HEMA) and
2-methacryloyloxyethyl phosphorylcholine (MPC) were used as received (Sigma-Aldrich) without
further purification. Camphorquinone (CQ), ethyl-4-(dimethylamino) benzoate (EDMAB) and
diphenyliodonium hexafluorophosphate (DPIHP) were obtained from Sigma-Aldrich (St. Louis,
MO, USA) and used as a three-component-photoinitiator system without further purification. ε-pL
hydrochloride was purchased from Bonding Chemical (Katy, TX, USA). To obtain ε-PL), 10 g ε-pL
hydrochloride was dissolved in 60 mL sodium bicarbonate buffer (NaHCO3, 1.5M) and dialyzed with
membrane (Spectra/Por®7 Dialysis Tubing, MWCO 1kD) in deionized water for 4 days. Then the
solution was dried at 37 ◦C and ε-pL was obtained.
2.2. Peptide Synthesis and Purification
The antimicrobial peptides: GH12 (GLLWHLLHHLLH), GH12-M1 (K_GGGSG_
GLLWHLLHHLLH) and GH12-M2 (GLLWHLLHHLLH_GSGGG_K) were synthesized by the
solid-phase peptide synthesizer (AAPPTEC Focus XC) through Fmoc-chemistry. Crude peptides were
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first cleaved from the resin and then purified by reversed-phase HPLC with Luna 10 µm C18 (2) 100 A,
250 × 4.6 mm column. HPLC fractions were analyzed for purity by analytical HPLC with Luna 5 µm
C18 (2) 100 A, 250 × 4.6 mm column. The purified peptide fractions were combined, lyophilized and
stored at −20 ◦C. The amino acid sequence of the peptides was confirmed by electrospray ionization
mass spectrometry using a Qtof Premier (Waters Corp., Milford, MA, USA) instrument. Sequence
confirming fragment ions were generated by collision-induced dissociation of peptide doubly charged
ions in the collision cell and mass-measured in the time-of-flight analyzer. Peptides were then desalted
and resolved from other components in the sample by RP HPLC on C18 media developed with a
water-CH3CN gradient and effluent delivered to the ESI source of the Qtof. Peptide solutions were
prepared fresh from stock powders for each experiment.
2.3. Streptococcus mutans UA159 Culture
Antimicrobial activity was assessed in an S. mutans UA159 bacterial strain (American Type
Culture Collection (ATCC 700610)). Following ATCC standard protocol, the lyophilized bacteria were
reconstituted in BHI medium (BD Difco) and streaked onto prepared BHI agar (BD Difco). The stock
culture plate was incubated for 24 h at 37 ◦C with 5% carbon dioxide (CO2). Overnight cultures
of S. mutans UA159 were prepared fresh, prior to each experiment, by inoculating 10 mL of fresh
BHI medium with a single colony selected from the stock culture plate and incubated for 16 h. The
overnight cultures were diluted in fresh BHI media and growth was monitored via optical density
measurements at 600 nm (OD600) on a Cytation3 multimodal plate reader (BioTek) [17].
2.4. Inhibitory Concentration (IC50) Assays
Inhibitory concentration assays were conducted using a standard broth microdilution method,
according to Clinical and Laboratory Standards Institute (CLSI) protocol [70]. Briefly, two-fold serial
dilutions of compounds were prepared with sterile deionized water to achieve concentrations ranging
from 5.0 to 2500 µg/mL in a volume of 20.0 µL, after which 80.0 µL of BHI (Brain Heart Infusion)
broth and 100.0 µL of bacterial culture containing 1.0 × 106 CFU/mL were added. Thus, each well
contained final peptide concentrations ranging from 0.5 to 250 µg/ml in a final volume of 200 µL
and a final bacterial concentration of 5.0 × 105 CFU/mL. Our protocol included chlorhexidine as the
positive control for antimicrobial function. As control samples, microwells containing chlorhexidine
digluconate (CHX) with concentrations ranging from 0.04 to 63 µg/mL were also combined with BHI
broth and bacterial culture. Although 20 µL of H2O was used as a negative control, we recognize that
the water effect may be creating different interface issues which may lead to slight variability in results.
The measurements were measured and recorded according to a blank subtraction. The experimental
blank controls consisted of 20 µL of H2O and 180 µL of medium without cells. The 96-well plate was
incubated in the presence of 5% CO2 at 37 ◦C overnight. The IC50 value was defined as the lowest
peptide, CHX, and ε-pL concentration corresponding to 50% inhibition of cellular viability measured
via AlamarBlue assay.
2.5. Preparation of Adhesive Formulations
Adhesive formulations are reported in Table 1 and experiments were conducted to study effects of
peptide coupling and antimicrobial activity of either a commercial analogue control or our experimental
ε-pL adhesive formulation. The control formulation contained HEMA/TEGDMA/MPC at 64/10/10
wt%, respectively, whereas the experimental formulation reduced the HEMA concentration by 5 wt%
to include ε-pL (ε-PL/HEMA/TEGDMA/MPC at 5/59/10/10 wt%, respectively). Water (14 wt%)
was added as the solvent to achieve more homogenous monomer solutions. The compositions of the
three-component initiator system were CQ (0.5 wt%), EDMAB (0.5 wt%), and DPIHP (1.0 wt%) with
respect to the total amount of monomers and solvent. Both the control and experimental resin mixtures
were prepared in amber vials and protected from light. The solutions were mixed for 24 h at room
temperature to promote complete dissolution and formation of a homogeneous solution.
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Table 1. Commercial analogue synthesis and ε-pL adhesive synthesis. HEMA: 2-hydroxyethylmethacrylate;
TEGDMA: triethylene glycol dimethacrylate; MPC: 2-methacryloyloxyethyl phosphorylcholine.
Component Commercial Analogue (wt%) ε-Polylysine (wt%)
HEMA 64 59
TEGDMA 10 10
MPC 10 10
ε-Polylysine / 5
Water 14 14
Photo-initiators 2 2
Total 100 100
Photo-initiators: Camphorquinone (CQ) 0.5 wt%, ethyl-4-(dimethylamino) benzoate (EDMAB) 0.5 wt%, and
diphenyliodonium hexafluorophosphate (DPIHP) 1.0 wt%.
2.6. Disc Specimen Preparation
Disc specimens were prepared by injecting the liquid resins into a standard aluminum hermetic
lid (Tzero®, P/N:901600.901) and covering them with a glass cover (22 mm × 30 mm, Fisherfinest®)
to prevent oxygen exposure. The specimens were light-cured for 40 s at 23 ± 2 ◦C with a
commercial visible-light-polymerization unit (Spectrum®, Dentsply, Milford, DE, USA) at an intensity
of 550 mW/cm2. The polymerized disc specimens were stored, protected from light, at 23 ± 2 ◦C for
at least 48 h. Subsequently, all specimens were prewashed by soaking in water (250 mL) for 5 days to
remove any unreacted components prior to antimicrobial assays. Water was changed daily.
2.7. Circular Dichroism
Circular dichroism (CD) was used to determine peptide folding in solutions containing 0–90%
(vol%) of trifluoroethanol (TFE) to mimic surface interactions. Spectra were recorded with a CD
spectrometer (JASCO, J-815) at room temperature, using a 1.0 mm cuvette. Each peptide sample was
dissolved at 0.2 mg/mL in 10 mM potassium phosphate containing 100 mM (NH4)2SO4 (pH 7.4) with
and without TFE at 4 ◦C for 16 h. A spectral range was acquired from 185 to 300 nm at a scanning
speed of 60 nm/min for each sample and reported values represent an averaged spectrum across
triplicate measurements. The secondary structure Far-UV CD spectra were processed with the tools of
CD Pro [71]. The mean residue ellipticity of each sample was converted to mean residue absorbance
and further processed with CRDATA.exe to create the input file for SELCON3.exe, CDSSTR.exe and
CONTILL.exe. For each set of data, the reference set selected was SMP50. The fractions of secondary
structure (Regular Helix, Distorted Helix, Regular Sheet, Distorted Sheet, Turns and Unordered) were
averaged for all three CD Pro tools (SELCON3, CDSSTR, and CONTILL).
2.8. Vibration Spectroscopy
2.8.1. Fourier-Transform Infrared Spectroscopy (FTIR)
The molecular structure of the synthesized antibacterial peptide was confirmed using FTIR
(Spectrum 400, Perkin-Elmer, Waltham, MA, USA), equipped with an attenuated total reflectance
(ATR) accessory (PIKE Technologies Gladi-ATR, Madison, WI, USA) at a spectral resolution of 4 cm−1.
2.8.2. Raman Spectroscopy
Lyophilized peptide powders were placed onto a clean microscopic glass slide. The samples were
mounted in a computer-controlled, high precision x-y stage. The Raman spectra were collected by
using an integrated fully automated confocal microscope (Horiba Jobin Yvon ARAMIS micro-Raman
microscope) equipped with internal laser excitation (HeNe: 632.8nm). The instrument conditions
were: 200 µm confocal hole, 150 µm wide entrance slit, 600 gr/mm grating, 20 s exposure time, and
100 × objective Olympus lens. Data processing was performed using LabSPEC 5 (HORIBA Jobin Yvon).
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2.9. Computational Structure Flexibility
To computationally assess peptide structure flexibility, structure decoys were generated with
PyRosetta tools using a developed protocol [54]. Briefly, Rosetta server fragments of lengths of 3 and
9 were randomly inserted into a decoy structure [72]. Inserted fragments resulting in a reduction
of energy, triggers the program to change the backbone of the decoy. Fragments not indicating
energy reduction are accepted with a probability inversely related to the exponential of the increase
of the energy. This fragment insertion method uses segments of determined protein structure, often
crystallized protein structure to search the peptide structural space. The observed percentage of
each secondary structure were calculated by the DSSP program at each peptide residue position [73].
Percentages for each peptide fragment were aggregated for direct comparison with collected CD
decomposition values using customized scripts.
2.10. Antimicrobial Activity Assays of Resin-disc Diffusion in Solution
In-solution antimicrobial activity of peptide-treated resin discs was assessed. For these studies,
each disc was soaked overnight in 100 µL sterile deionized water, peptide, or CHX solution at 4 ◦C.
The soaked discs were rinsed 4 times with 100 µL of H2O, with excess H2O on the disc surface gently
removed by blotting with Kimwipes. Each soaked and rinsed disc was carefully transferred to a
microwell of a 96-well plate. 20 µL H2O, 80 µL of BHI broth and 100 µL of BHI broth containing
1 × 106 CFU/mL S. mutans UA159 cells were added to each well. The final bacterial concentration in
each well was 5.0 × 105 CFU/Ml [74]. S. mutans UA159 bacteria without any disc present served as the
positive control and the negative control was 20 µL of 63 µg/mL CHX solution instead of H2O. The
blank well contained 20 µL H2O and 180 µL medium without cells. The 96-well plate was incubated in
the presence of 5% CO2 at 37 ◦C overnight. The solution of each well was transferred to a new plate
and the OD600 was recorded by Cytation3.
Absorbance-based in-solution measurements rely on turbidity at OD600 and therefore do not
provide quantitative delineation between viable and non-viable S. mutans UA159 cells. Thus, an
alternative fluorescent method, described below, was used to ensure the antimicrobial activity of the
system was accurately assessed.
2.11. Fluorescence-Based Bacterial Viability Assays
The viability of S. mutans bacteria was measured using an AlamarBlue (ThermoFisher Scientific)
assay [75]. Cellular activity was measured via fluorescence spectroscopy (Ex/Em 565/595 nm)
following the bacteria’s metabolic conversion of resazurin to the fluorescent molecule, resorufin.
Following the manufacturer’s protocol, S. mutans bacteria were grown overnight in a 96-well plate
format. Following mixing the solution via pipette, 5 µL of bacterial culture was transferred to a new
plate having 195 µL of fresh BHI broth in each well. Next, 20 µL of AlamarBlue dye (10 %vol.) was
carefully added into each well and gently mixed. All samples were allowed to wait for 2 h to properly
metabolize the reagent in the presence of 5% CO2 at 37 ◦C prior to fluorescent activity measurements.
2.12. Statistical Analyses
For all experimental groups, the differences were evaluated using one-way analysis of variance
(ANOVA), together with Tukey’s test at α = 0.05 to identify significant differences.
3. Results and Discussion
3.1. Antibacterial Activity of the Peptide
Table 2 and Figure 1 provide the antimicrobial efficacy of the peptides explored in this study.
In addition to the GH12 peptide sequence we explored the sequence modifications for this peptide
for effective delivery into the adhesive formulations [67]. We first synthesized a sequence featuring
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a lysine residue, attached via a spacer sequence [43] then we changed the C-terminal of the peptide
to COOH since this would replace the adhesive’s lost carboxy functional groups due to the peptide
conjugation. The next design choice was aimed to select the peptide terminus to attach the spacer
sequence that would allow for optimal antimicrobial activity. As the control, we used the GH12-NH2
(with an C-terminal amide), the reported MIC value of GH12-NH2 was about 6.7 µg/mL against
S. mutans [67]. The GH12 peptide was synthesized to feature a carboxyl group to allow for further
sequence modifications involving additional amine-containing moieties such as polypeptide chains or
monomers. Next, we designed GH12-M1 to include a spacer domain featuring a single lysine residue
at the N-terminal for coupling to the polymer. Additionally, a GH12-M2 peptide was created with
the same spacer sequence and single lysine residue as GH12-M1, but placed at the C-terminus of
the peptide.
The activity of each peptide was evaluated against S. mutans UA159 using an inhibitory
concentration (IC50) assay. The minimum inhibitory concentration (MIC) values for all synthesized
peptides were calculated at 31.7 µg/mL (Figures S1–S5). CHX was used as a positive control and
exhibited an IC50 value of 0.37 µg/mL. The IC50 of GH12, GH12-M2, and GH12-M1 were found 11.6,
12.8, and 17.1 µg/mL, respectively. We next investigated the addition of ε-pL to our formulation which
resulted in the IC50 value about 71.3 µg/mL. The N-terminal modification (GH12-M1) demonstrated a
larger IC50 value indicating reduced activity when compared to the unmodified peptide (See Table 2).
The spacer modification carried out at the C-terminal (GH12-M2) resulted in a slight increase in the
IC50 value as compared to the unmodified form. GH12-M2 was therefore selected for further coupling
studies due to its superior antimicrobial efficacy as well as flexibility allowing for more direct coupling
to an adhesive formulation.
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Figure 1. Antibacterial activity of chlorhexidine (CHX), antibacterial peptides and ε-polylysine against
S. mutans.
Table 2. Properties of antimicrobial peptides, i.e., GH12, and its modifications, and ε-polylysine.
Peptide Sequence S. MutansIC50 (µg/mL)
S. Mutans
MIC (µg/mL)
GH12-NH2 GLLWHLLHHLLH (-NH2 ) - 6.7 *
GH12 GLLWHLLHHLLH (-COOH) 11.6 31.3
GH12-M1 K_GGGSG_GLLWHLLH LLH 17.1 31.3
GH12-M2 GLLWHLLHHLLH_GSGGG_K 12.8 31.3
ε-Polylysine (ε-Lysine)n 71.3 125
* As reported by Tu, et al., in a 2016 study.
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3.2. Effect of Peptide Conformation on Function
Structure-function relations are critical in peptide function, hence we explored the structural
differences that may occur between modified GH12-M2 and unmodified GH12 prior to studies on
peptide coupling to adhesive formulation. First, we performed circular dichroism spectroscopy to
investigate the secondary structure and folding properties of the peptides in solution. We used different
buffers to test the conformation of the peptides including a range of concentrations of trifluoroethanol
(TFE) to mimic their folding behavior at the solid interfaces. The circular dichroism spectrum was
relatively flat for GH12 without TFE in ammonium sulfate and potassium phosphate buffers at pH 7.4
with a negative peak near 230 nm as shown in Figure 2. The CD spectrum for GH12-M2 in buffer only
showed a similar trend to GH12, with a negative peak near 235 nm. In the presence of 10% TFE, spectral
flattening still occurred for both peptides with a slight increase in the MRE near 185 nm. Increasing
the TFE to 20% resulted in a large difference in the CD spectrum among the peptides. Specifically, the
GH12-M2 peptide in the 20% TFE solution demonstrated spectral features characteristic to the helical
formation of secondary structure, including a large, positive peak near 190 nm and negative peaks
near 205 and 225 nm. In contrast, the GH12 peptide alone did not show this behavior in the same 20%
TFE solution. However, TFE concentrations of 40% and above elicited spectra characteristic to helical
features for both the GH12 and GH12-M2 peptides.
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Detailed spectral deconvolution analysis was conducted to identify the probability fractions of the
relevant secondary structures including regular and disorder helices and sheets, turns, and unordered
folding. The analysis revealed that GH12 and GH12-M2 have similar secondary structure fractions in
the absence of TFE, with the regular helix fraction slightly larger (3% versus 0%) for the GH12 peptide.
With 10% TFE in the buffer solution, the result is a similar distribution of secondary structure fractions
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to the peptides in buffer only. For GH12, the addition of 10% TFE to the buffer reduced the potential of
the regular helix so that all the categories are within 1–2%. At solutions with 20% TFE, we observed a
large difference between the secondary structure fractions for GH12 and GH12-M2, consistent with the
original CD spectra results. GH12-M2 resulted in more regular and distorted helical features (38%)
compared to GH12 (4%). Regular sheet and distorted sheet fractions were greater for GH12 (44%)
versus GH12-M2 (15%). At high TFE concentrations (>20%), the two peptides stabilize in the fractions
of their CD deconvolution. The GH12 peptide in solutions containing 40% and greater TFE exhibit a
larger turn fraction (21–23%) and smaller helix fraction (37–38%) than calculated for GH12-M2 turns
(16–17%) and helix fraction (42–43%).
In agreement with previous studies, GH12 exhibits αhelix conformations in solvents mimicking
interactions at the membranes [76]. Our results are in agreement with the trends that are shared by the
modified GH12 and GH12-M2. Due to significant differences in the structural analyses of CD, we did
further characterization using Fourier transform infrared (FT-IR) and Raman spectroscopy.
3.3. Vibrational Spectroscopy
The secondary structure of GH12 is noted in the FT-IR spectra of GH12 and the modified derivative,
GH12-M2. Peptides were compared to identify any significant spectral similarities and differences.
FT-IR revealed common spectral features associated with secondary structure features for both peptides.
We observed two maxima in the Amide I region at 1658 cm−1 and 1652 cm−1, a peak at 1536 cm−1 in the
amide II region, and a peak at the 1338 cm−1 in the amide III region for both peptides (Figure 3a). The
characteristic Amide I peaks at 1658 cm−1 and 1652 cm−1 can be attributed to α-helical conformation. A
peak at 1536 cm−1 is correlated to the presence of random coil. The peak at 1338 cm−1 also indicated the
presence of α-helical structures whereas the peaks at 1259 cm−1 are assigned to unordered secondary
structures and turns [77]. The only notable difference between the two peptide spectra occurred at
1027 cm−1, a spectral feature associated with CH3, N-H, C-N bending and stretching appearing in the
spectra for GH12-M2 (Table 3).
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no measurable effect on its folding properties derived from Raman spectral analysis. Both peptides
contained the spectral bands of 1337, 1428, and 1652 cm−1 characteristic of an α-helix conformation, the
CH2CH3 deformation, and a β-strand conformation, respectively (Table 4) [78–82]. The intensity ratios
of two bands 1617 cm−1 and 1652 cm−1 in the Amide I region for GH12 and GH12-M2 were 0.6 and
0.5, respectively (Figure 3b). The similar ratios between these two peptides indicates further agreement
of the hydrogen bonding patterns measured in the Amide I region. We further explored the likely
residues involved in forming helical secondary structure through computational structure flexibility.
Table 3. FTIR spectroscopy of GH12 and GH12-M2.
Peak Region Name Peak (cm−1) Peptides
Amide I 1658, 1652 (α-helical structures) GH12 (twin), GH12-M2
Amide II 1536 GH12, GH12-M2
Amide III 1338 (α-Helical structures) GH12, GH12-M2
Amide III 1259 (Unordered/turn) GH12, GH12-M2
CH3,N-H,C-N
stretching-bending [83] 1027 GH12-M2
Table 4. Raman spectra of GH12 and GH12-M2 by Diode785.
Shift Peak Structure Shift Peak (cm−1) Peptides
α-Helical structures 1617, 1652 GH12 (ratio: 0.6), GH12-M2 (ratio: 0.5)
CH2CH3 deformations 1428 GH12, GH12-M2
β-Strand conformation 1259 GH12, GH12-M2
Unordered/turn 856, 828 GH12, GH12-M2
The α-helix secondary structure of GH12 is a design target for functional integration of the
peptide to the adhesive system [76]. The presence of α-helix conformation was confirmed through
our vibrational spectroscopy measurements for peptides including the modified GH12. We further
explored the likely residues involved in forming α-helix conformations through computational
structure flexibility.
3.4. Computational Structure Flexibility
Secondary structures of peptide sequences can also be computationally predicted by generating
structure decoys through PyRosetta. The distribution of predicted secondary structural features as
a function of sequence residue for GH12 and GH12-M2 are shown in Figure 4a,b. Darker colors
denote higher frequencies of the feature labeled at the right-hand side. The residue positions with the
highest occurrence of alpha helix are residues 3–7 (LWHLL). The residues with the highest predicted
three-helix structure frequencies are residues 3–5 (LWH). It should be noted that the first residue and
last two residues cannot be labeled with these three-helix structure features because the definition used
by DSSP (Define Secondary Structure of Proteins) requires the presence of adjacent residues. Bends
(which are not helices) peaked at residues 5, 9, and 10. Turns, not defined as bends or helices, peaked
at residues 2 and 3. The bottom two rows are defined by the direction in which the peptide backbone
rotates. For about 80% of the decoys, the leucine at residue 2 is turned right, from residue 3 to 6 about
70% of decoys are turned right, and for residues 7–10 about 60% of the decoys. Figure 4c shows the
helix in the GH12 peptide backbone ribbon for the lowest energy score decoy.
Figure 4d represents the GH12-M2 peptide backbone ribbon structure for the decoy with the
lowest calculated energy score. Noα-helical secondary structure was predicted for this decoy. However,
the sequence modification of M2 (GSGGGK) did induce a change in the flexibility analysis results
across residues 2–10 as compared to the same residues of the GH12 decoy. Even though no helix
features were predicted for the lowest energy score decoy, 310-helix structures were observed for about
10–20% of decoys across residues 2–7. The percentages of α-helix dropped below 10% for all residues
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of GH12-M2 compared to α-helix structure predictions above 10% for residues 3–7 for GH12. The
GH12-M2 flexibility features of bend were calculated in residues 14 and 16 in about 50% of the decoys.
The right and left turn frequencies were similar to those observed for GH12, with a 50–50% split for the
spacer residues. Although the structural analysis of CD for both GH12 and our modified derivative
peptide, GH12-M2, showed significant differences, FT-IR and Raman spectra analyses of both GH12
and GH12-M2 displayed only slight variations.
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The difference in structure flexibility between GH12 and GH12-M2 appeared negligible in
accordance with the fragment insertion method employed by PyRosetta. The decoy generation
method is stochastic and therefore cannot accurately predict flexibility changes if the lowest energy
structures possible are found. o ever, the lo est energy structure ay differ from the native
structure [84,85]. The parallel optimization of many decoys at once may also provide insight into the
distribution of the ensemble of structures sampled by peptides in solution. Peptides are not static
when floating in solution, instead they are often modeled as dynamic mechanical systems of springs
and masses. constantly in motion [45,86].
The computational folding model and the circular dichroism easurements agreed with results for
increasingly ordered water conditions with TFE in the buffering solution, but not for the less-ordered
water conditions with phosphate-buffer only. The computational folding model used an implicit
solvent method, which provided a faster structure generation process. Another advantage to the
implicit solvent model was the averaging of the solvent conditions of ordered peptide states, which are
closely related to the environmental conditions of the fragments when the structure was determined.
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This environment was not in disordered conditions such as in a dilute aqueous solution, rather
fragments were obtained from crystallized structures in ordered environments.
The computational folding model estimated a higher occurrence of helical structures, while the
deconvolution of the CD spectra by CD Pro predicted mainly beta-sheet structures for peptides in
buffer only. However, the deconvolution method observed large increases in the helical structures
with increasing amounts of 2,2,2-trifluoroethanol (TFE) in the solution. TFE is a known kosmotropic
agent, increasing the order of the water near the surface of biomolecules [87]. TFE has long been used
in the crystallization of proteins. The increased TFE concentrations were expected to put the peptides
in an ordered, structured state [88,89]. The computational folding model held a bias toward native,
ordered structures because it used fragments from crystallized structures. Whereas fragment-insertion
structures generated were representative of kosmotropic agent-related peptide structures, obtained
with the increasing levels of TFE. The method held a bias against generating structures representative of
peptide structures with chaotropic agents such as would likely be observed with urea or guanidinium
chloride. The water near bacterial surfaces is likely also highly ordered, due to the biomolecules of
the bacterial membrane [76,90]. Since our structure generation method searched the portions of the
structural space with ordered fragments, it may provide structures representative of bacterial surface
interactions for structure–function relationships. We next explored the functionality of the peptide
engineered adhesive formulations on the discs.
Incorporation of additional functionality to antimicrobial peptides benefits from detailed analyses
of the structure-function relationships on the resulting peptides as discussed in our group’s recent
papers on antimicrobial peptides based coatings or films [43,44,54,91]. In this study design, we
investigated if residues of the spacer domain added for the conjugation to the polymer affect the
peptide folding, which in turn may have an adverse effect on the antimicrobial property. We observed
similar circular dichroism spectra for GH12 and GH12-M2 in Figure 2. We also obtained similar
analyses for both peptides using FTIR and Raman spectra as shown in Figure 3. Almost no difference
in structural flexibility in the peptide models were observed (Figure 4). The similarity of observed and
computationally predicted structure between GH12 and GH12-M2 gives an indication that GH12-M2
is a good candidate to conjugate to the resin without losing its activity.
3.5. Bacterial Viability on Treated Discs
We first explored if the resin formulations have any antibacterial effects, we prepared discs
using both commercial analogue and ε-pL polymerized discs. The discs were soaked in water
overnight for a baseline control. Neither formulation exhibited any innate antibacterial activity
against S. mutans. We next tested the antibacterial activity on the discs soaked in antimicrobial
peptide solutions across a range of concentrations up to 50× the minimum inhibitory concentration
(MIC) (1560 µg/mL). The ε-pL discs soaked with peptide solutions exhibited significant antibacterial
activity against S. mutans. Complete bactericidal efficacy was observed for ε-pL discs soaked in
GH12-M2 peptide at 25× MIC value (780 µg/mL). Near complete reduction in S. mutans growth was
observed at 12.5× MIC (390 µg/mL), however antibacterial activity was not statistically significant at
concentrations of 6.25× MIC (195 µg/mL) and below for the GH12-M2 peptide. The positive control
studies included discs that are soaked in chlorhexidine (CHX), where robust antimicrobial property
was observed for both discs, but the CHX showed higher growth inhibition in the commercial analogue
discs as compared to the ε-pL formulation discs. CHX-soaked discs exhibited complete bactericidal
efficacy against S. mutans at 25× and 12.5× MIC concentration for each disc formulation. While,
the CHX was effective in both disc formulations at different levels, GH12-M2 peptide demonstrated
antibacterial activity in disc formulations featuring ε-pL. These results indicate a critical dependence
on the adhesive formulation to incorporate functional peptides.
Though the ε-pL discs coupled with GH12-M2 peptide demonstrated bactericidal efficacy at
concentrations of 390 µg/mL and 780 µg/mL, commercial analogue discs coupled with peptide at
these concentrations did not show any significant bactericidal efficacy. Engineering the peptide to the
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adhesive formulation has a synergetic antibacterial effect when incorporated into ε-pL adhesive system,
while commercial analogue for the same peptide concentrations did not show similar synergetic effect
(Figure 5). The results demonstrate the importance of biocompatible adhesive system to induce
antimicrobial effects through novel antimicrobial agents. An increased occurrence of affinity and
non-specific interactions of the GH12-M2 peptide with commercial analogue resin discs was noted
based upon the observed reduction in bacterial viability at peptide concentrations of 390 µg/mL
and 780 µg/mL, as seen in Figure 5b. The hydropathy of the resin with ε-polylysine is hydrophilic
and highly positively charged, unlike bacterial membranes. Since the commercial analogue is more
hydrophobic, the peptide is likely adsorbing to the resin with the similar hydrophobic interactions,
such as hydrogen bonding and van der Waal forces, that occur in the bacterial membrane [92].
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Figure 5. (a) Schematic of adhesive system samples starting with commercial analogue. Experiments
included the addition of GH12-M2 antimicrobial peptide onto the discs with ε-polylysine to see bacterial
inhibition. As a positive control for antimicrobial activity, chlorhexidine gluconate was added at a
multiple of its measured MIC value. 12.5× or greater concentration of CHX was sufficient for bacterial
inhibition with or without ε-polylysine. (b) S. mutans UA159 growth/viability based on AlamarBlue
assay on dental adhesive discs soaked with either an antimicrobial peptide or a chlorhexidine aqueous
solution as a multiple of minimum inhibitory concentration.
The delivery mechanism of the antimicrobial agents, either the peptide or the CHX, is based
on the non-specific adsorption of the agent to the resin. The antimicrobial agents are coupled to the
resin through adsorption overnight before the bacteria are added to the resin material. Unbound
agent is also rinsed off before bacteria are added. Therefore, only the adsorbed agent is available
for any bactericidal effect. However, the resin must act as a delivery system so that the adsorbed
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agent is active against the introduced bacteria. The non-specific adsorption of the peptide to the
commercial analogue resin appears to be more stable than the potential interactions taking place
between either the peptide and the ε-polylysine disc or the CHX and both resin discs. The stability
of this non-specific adsorption for antimicrobial peptides on polymeric materials are considered as a
result of the similarities between polymers and bacterial membranes [92]. Non-specific interactions
of antimicrobial peptides with polymers that mimic bacteria membranes limit their availability for
antibacterial efficacy. Thus, there is a challenge to overcome these non-specific interactions. Our
approach is to provide an adequate orientation of the peptide away from the resin through coupling
the antimicrobial peptide to the resin with a spacer domain in between the peptide and the resin.
The spacer domain is always anchored to the resin. Anchoring the peptides to the resin minimizes
the interactions between peptides. Several studies including ours have shown that spacer domains
provides flexibility for peptides to keep their active conformation while they interact with the surfaces,
which improves their biological function [43,54,93]. For example, a rigid spacer was shown to improve
the antibacterial activity of a peptide compared to a flexible spacer of the same length [43]. In this work
it was noted that the addition of a spacer sequence, flexible or rigid, allowed greater functional activity
of the peptides coupled to the resin, when compared to respective peptides without a spacer [93].
Overall spacer design approach which was inspired by the domain linker sequences observed in
multi-domain proteins, provided an active orientation for the antimicrobial peptide when coupled to
the adhesive formulation. [94,95].
4. Conclusions
A dental adhesive formulation with ε-polylysine was designed to incorporate antimicrobial
peptide to target S. mutans. The choice of ε-polylysine as dental adhesive was inspired due to its
non-toxic nature. Our studies included design of peptides with different modification for their effective
coupling to adhesive formulations. The peptides were first designed and tested for their antimicrobial
activity in solution. We then performed complementary structural characterization and computational
modeling methods to understand the effect of the helical conformations of GH12, which is a design
target for the synthetic peptide. As we modified the peptide, structural properties of the peptide
were investigated to relate its antimicrobial functionality prior to designing peptide coupled adhesive
formulations. The peptide conformation was depicted at the solid interfaces both computationally and
experimentally using a kosmotropic agent, TFE. At higher TFE concentrations, peptides demonstrated
spectral features characteristic to the helical formation of secondary structure. The α-helix secondary
structure of the modified GH12 was next confirmed through vibrational spectroscopy measurements.
Building upon the expected structures of the peptides that can provide functionality, we finally
explored the antimicrobial property of the peptide-adhesive formulations, i.e., ε-polylysine and
commercial analogue adhesive system. The peptide adhesive formulation demonstrated significant
antimicrobial activity against S. mutans when applied to the discs that are made of ε-polylysine.
Interestingly, the antimicrobial property of the commercial analogue adhesive system when soaked
with antimicrobial peptide was limited. These results indicate the critical importance of presenting
biofunctionality when developing adhesive formulations coupled with molecular novel agents. Our
results demonstrate that bio-enabled dental adhesive system provides bacterial inhibition to be
employed at the adhesive/dentin interface.
Antimicrobial peptides offer a promising solution to antibiotic resistance, staining, and mucosal
irritation issues related to existing approaches. Our results demonstrate that antimicrobial peptides can
be coupled with dental adhesive formulations using a simple, one-step soaking process. The peptide
structure–function analyses indicate that peptides can also be incorporated with additional functional
groups that will allow them to conjugate to different monomer/polymer combinations. Integrating an
antibacterial activity through a bio-active molecule conjugation within an adhesive provides a path for
integrating various biofunctions at the interface of hybrid materials. This methodology may also be
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applied to integrate bio-active molecular activity into polymeric materials ranging from medical to
diverse engineering applications.
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